Wockhardt

Wockhardt Limited is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. The company manufactures and markets pharmaceutical formulations, active pharmaceutical ingredients (APIs), and vaccines. It operates across various therapeutic areas, including anti-infectives, cardiovascular, pain management, respiratory, and diabetes.

Wockhardt has a global presence, with manufacturing facilities and research and development centers located in India, Europe, and the United States. The company's products are sold in numerous countries worldwide.

Founded in the 1960s by Habil Khorakiwala, Wockhardt has grown through acquisitions and organic growth. It has faced regulatory challenges and scrutiny in the past related to manufacturing practices and data integrity at some of its facilities. These issues have led to import alerts from regulatory agencies like the US Food and Drug Administration (FDA). The company has been working to address these issues and regain regulatory compliance.

Wockhardt's business strategy focuses on research and development, strategic partnerships, and expanding its global footprint. The company aims to develop and market innovative pharmaceutical products to meet unmet medical needs.